Does the atherogenic index of plasma predict subclinical coronary and carotid atherosclerosis in a health screening population?
The atherogenic index of plasma may serve as a useful biomarker for identifying early subclinical coronary and carotid atherosclerosis in screening populations.
AIP may help identify early subclinical coronary and carotid atherosclerosis, and sequential adjustment with metabolic indicators improves predictive performance. External validation is warranted.
Li et al. (Mon,) studied this question.